Vitamin D does not improve glycemic control in prediabetes

Vitamin D does not improve glycemic control in prediabetes

(HealthDay)—Supplementation with vitamin D does not appear to improve glycemic indices or cardiovascular risk factors in individuals with prediabetes, according to research published online June 19 in Diabetes Care.

Stina Therese Sollid, of the University of Tromsø in Norway, and colleagues randomly assigned 511 individuals with (IFG) or impaired glucose tolerance (IGT) to vitamin D3 or placebo.

At one year, the researchers observed no differences between the vitamin D group and placebo group in measures of glucose metabolism, insulin secretion, or insulin sensitivity. No differences were observed between the groups for blood pressure or serum high-sensitivity C-reactive protein level. Although a small but significant decrease in total and low-density lipoprotein cholesterol levels was observed in the vitamin D group compared with the , high-density lipoprotein (HDL) cholesterol level decreased, and the change in total/HDL cholesterol ratio was not significant.

"This study shows that vitamin D supplementation does not improve glycemic indices, blood pressure, or lipid status in subjects with IFG and/or IGT," the authors write.


Explore further

Calcium and vitamin D supplementation improves metabolic profile of pregnant women with gestational diabetes

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: Diabetes Care

Copyright © 2014 HealthDay. All rights reserved.

Citation: Vitamin D does not improve glycemic control in prediabetes (2014, July 3) retrieved 28 February 2020 from https://medicalxpress.com/news/2014-07-vitamin-d-glycemic-prediabetes.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments